Core Insights - The Carlyle Group Inc. (CG) reported a 5.9% increase in shares during Friday's trading session, with fourth-quarter 2025 post-tax distributable earnings per share of $1.01, matching the Zacks Consensus Estimate and improving from 92 cents per share in the previous year [1][8] Financial Performance - Net income attributable to Carlyle was $358.1 million, up from $210.9 million in the year-ago quarter, while for 2025, post-tax distributable earnings per share were $4.02, slightly missing the Zacks Consensus Estimate of $4.03 but increasing from $3.66 in 2024 [2] - Fourth-quarter segmental revenues reached $1.09 billion, a 15.1% increase from the previous year, matching the Zacks Consensus Estimate [3][8] - Total segment fee revenues rose 2.3% year over year to $669.9 million, driven by increased fund management fees and fee-related performance revenues, while realized performance revenues surged 46.8% to $360.8 million [4] Expenses and AUM - Total segmental expenses increased by 16.1% year over year to $655.4 million, presenting a challenge to overall profitability [4][8] - As of December 31, 2025, total assets under management (AUM) were $476.9 billion, reflecting an 8.1% increase from the prior year, with fee-earning AUM rising 10.6% to $336.8 billion [5] Capital Distribution - In the reported quarter, Carlyle repurchased or withheld 3.8 million shares for $204 million, with $0.2 billion worth of shares remaining under authorization [6] - The company declared a quarterly dividend of 35 cents per share, scheduled for payment on February 20, 2026 [6] Strategic Outlook - The increase in total AUM and efforts to expand investment platforms are expected to support long-term revenue growth for Carlyle, although rising expenses and a competitive financial environment pose challenges [7]

Group 1 - The Carlyle Group is a global investment firm managing assets across private equity, real estate, and credit, with Barclays maintaining an "Overweight" rating and raising its price target from $65 to $71 [1][5] - Carlyle's stock has a high volatility with a beta of 2.05, making it 105% more volatile than the S&P 500, which may attract investors looking for higher returns [2][5] - Analyst recommendations for Carlyle Group show a favorable rating score of 2.38, indicating stronger confidence compared to Portman Ridge Finance, which has a score of 2.00 [3][5] Group 2 - Carlyle Group's market capitalization is approximately $21.16 billion, with a trading volume of 3,573,897 shares on NASDAQ, and the stock has experienced significant price movement over the past year [4] - The current stock price of Carlyle is $58.71, reflecting a 5.96% increase, with a trading range between $57.67 and $61.22 [3]

Core Insights - Carlyle Group Inc. reported an earnings per share (EPS) of $1.01, slightly below the estimated $1.03, while revenue reached approximately $1.09 billion, surpassing the estimated $1.07 billion [1][6] Financial Performance - The fourth-quarter results showed fee-related earnings growing by 12% year-over-year, reaching a record $1.2 billion, which doubled the firm's original goal [2] - Fourth-quarter distributable earnings increased by 14% from the previous year, amounting to $436 million [2] Fundraising and Capital Deployment - Carlyle raised $53.7 billion in fresh capital during 2025, supported by its credit and AlpInvest platforms [3] - The firm deployed $54.5 billion over the same period and generated $34 billion from asset sales, including the IPO of Medline [3] Financial Metrics - The company has a price-to-earnings (P/E) ratio of approximately 31.96, indicating investor confidence [4] - The price-to-sales ratio stands at about 5.73, reflecting the market's valuation of its revenue [4] - The enterprise value to operating cash flow ratio is negative at -12.56, suggesting challenges in cash flow generation [4] Leverage and Returns - Carlyle's debt-to-equity ratio is 2.25, highlighting its financial leverage [5] - The earnings yield is approximately 3.13%, providing insight into the return on investment for shareholders [5]

Core Viewpoint - OXLC has recently cut its dividends, raising concerns that similar actions may occur among its peers, specifically Carlyle Credit Income Fund (CCIF) and OFS Credit Company Inc (OCCI) [1] Group 1: Company Actions - OXLC has reduced its dividends, which may indicate financial distress or a strategic shift [1] - The potential for dividend cuts in CCIF and OCCI is highlighted, suggesting a broader trend in the sector [1] Group 2: Investment Strategies - Denislav Iliev, with over 15 years of day trading experience, leads a team that focuses on identifying mispriced investments in fixed-income and closed-end funds [1] - The investment group Trade With Beta offers features such as frequent picks for mispriced preferred stocks and baby bonds, along with weekly reviews of over 1200 equities [1]

Financial Data and Key Metrics Changes - 2025 was a record year for the company, with fee-related earnings (FRE) up 12% year-over-year, reaching a margin of 47% [5][17] - Total inflows amounted to $54 billion, significantly exceeding the original target of $40 billion, representing a 32% increase year-over-year [5][18] - Distributable earnings (DE) for 2025 were $1.7 billion, or $4.02 per share, an 11% increase from the previous year [16][17] - Total fee revenues reached a record $2.6 billion for the full year, reflecting a 10% organic growth rate [17] Business Line Data and Key Metrics Changes - Carlyle AlpInvest generated a record $274 million of FRE for the year, up nearly 60% [19] - Global Credit delivered a record $402 million of FRE for 2025, up 21% from the prior year [21] - Global private equity realized over $18 billion of proceeds in 2025, the highest level in the past three years [22] Market Data and Key Metrics Changes - The company was the number 1 private equity sponsor globally by IPO proceeds, generating approximately $10 billion of IPO issuance over the past two years [7][8] - The IPO of Medline raised over $7 billion, marking it as the largest sponsor-backed IPO of all time [8] - CLO inflows of $7 billion in 2025 were up almost 20% from the prior year, with the company being the most active CLO manager for U.S. activity [11] Company Strategy and Development Direction - The company aims to continue building on its strategy of investment performance, disciplined capital allocation, and delivering long-term value for investors [14] - There is a strong focus on expanding in global wealth, insurance solutions, and asset-backed finance, with significant opportunities identified in each area [17] - The company plans to host a shareholder update to share multi-year financial targets and insights into its strategic direction [15] Management's Comments on Operating Environment and Future Outlook - The macro environment in 2025 was resilient despite geopolitical concerns, with M&A and IPO activity accelerating [7] - Management expressed confidence in the sustainability of monetization momentum into 2026, citing strong January data from their portfolio [29] - The economic engine appears strong, with good GDP growth and EBITDA generation expected [29] Other Important Information - The company returned $18 billion of capital to investors in 2025, consistent with the previous year [9] - The balance sheet remains strong, with $2 billion in cash and over $3 billion in investments [22] Q&A Session Summary Question: Thoughts on sustainability of monetization momentum into 2026 - Management is optimistic about the sustainability of monetization momentum, citing strong January data and good economic indicators [29] Question: State of play in direct lending and credit quality - Management feels well-positioned in direct lending and has been systematic in building their credit business, which is diversified and durable [36][38] Question: Expectations for management fee growth in 2026 - Management indicated that detailed insights will be provided in the upcoming shareholder update, but they are confident in their diversified fundraising pipeline [58] Question: Exposure to software in CLOs and impact of recent volatility - Management stated that their CLO performance has been strong and does not expect recent market volatility to affect them significantly [61] Question: Steps to enhance originations in the credit business - The company has made significant hires to enhance its origination capabilities and achieved record originations in 2025 [95]

Financial Data and Key Metrics Changes - 2025 was a record year for the company, with fee-related earnings (FRE) up 12% year-over-year, reaching a margin of 47% [5][17] - Total inflows amounted to $54 billion, significantly exceeding the original target of $40 billion, representing a 32% increase year-over-year [5][18] - Distributable earnings (DE) for 2025 were $1.7 billion, or $4.02 per share, an 11% increase from the previous year [16][19] - Total fee revenues reached a record $2.6 billion for the full year, reflecting a 10% organic growth rate [17] Business Line Data and Key Metrics Changes - Carlyle AlpInvest generated a record $274 million of FRE for the year, up nearly 60% [19][20] - Global Credit delivered a record $402 million of FRE for 2025, up 21% from the prior year [20][21] - Global Private Equity realized over $18 billion of proceeds in 2025, the highest level in the past three years [22] Market Data and Key Metrics Changes - The company was the number 1 private equity sponsor globally by IPO proceeds, generating approximately $10 billion of IPO issuance over the past two years [7][8] - The IPO of Medline raised more than $7 billion, marking it as the largest sponsor-backed IPO of all time [8][9] - CLO inflows of $7 billion in 2025 were up almost 20% from the prior year, with the company being the most active CLO manager for U.S. activity [11][20] Company Strategy and Development Direction - The company aims to continue building on its strategy of investment performance, disciplined capital allocation, and delivering long-term value for investors [14][23] - There is a strong focus on expanding the Global Wealth segment, with significant progress made in 2025 [12][14] - The company plans to host a shareholder update to share multi-year financial targets and insights into its strategic direction [15][23] Management's Comments on Operating Environment and Future Outlook - The macro environment in 2025 was resilient despite geopolitical concerns, with M&A and IPO activity accelerating [7][14] - Management expressed confidence in the economic engine, citing positive January data from their portfolio [29] - The company anticipates continued growth supported by a diversified fundraising pipeline and improving capital markets conditions [23] Other Important Information - The company returned a record $1.2 billion of capital to shareholders through dividends and share buybacks during 2025 [22] - The balance sheet remains strong, with $2 billion in cash and over $3 billion in investments [22] Q&A Session Summary Question: Sustainability of monetization momentum into 2026 - Management is optimistic about the economic engine and January data looks promising, but acknowledges market volatility [28][29] Question: State of play in direct lending and credit - Management feels well-positioned for growth in direct lending and has added key leaders to enhance origination [36][38] Question: Software exposure and CLO performance - The company has a low software exposure of 6% and CLO performance has been strong, with no expected impact from recent market volatility [40][60] Question: Capital raising and Fund 9 status - Management is confident in fundraising capabilities and will provide more insights in the upcoming shareholder update [56][57] Question: Outlook for CLOs in 2026 - The CLO market is expected to remain active, with the company well-positioned due to recent deal extensions [90] Question: Enhancements in credit originations - The company has built a strong origination team and achieved record originations in 2025, with plans for continued growth [95][96]

Financial Data and Key Metrics Changes - 2025 was a record year for the company, with fee-related earnings (FRE) up 12% year-over-year, reaching a margin of 47% [4][15] - Total inflows amounted to $54 billion, significantly exceeding the original target of $40 billion, and representing a 32% increase year-over-year [4][16] - Distributable earnings (DE) for 2025 were $1.7 billion, or $4.02 per share, an 11% increase from the previous year [13][15] - Total fee revenues reached a record $2.6 billion for the full year, reflecting a 10% organic growth rate [15] Business Line Data and Key Metrics Changes - Carlyle AlpInvest generated a record $274 million of FRE for the year, up nearly 60% [17] - Global Credit delivered a record $402 million of FRE for 2025, up 21% from the prior year [18] - Global private equity realized over $18 billion of proceeds in 2025, the highest level in the past three years [19] Market Data and Key Metrics Changes - The company was the number 1 private equity sponsor globally by IPO proceeds, generating approximately $10 billion of IPO issuance over the past two years [5][6] - The IPO of Medline raised more than $7 billion, marking it as the largest sponsor-backed IPO of all time [6] - Direct lending had a record quarter of originations, with CLO inflows of $7 billion in 2025, up almost 20% from the prior year [9][10] Company Strategy and Development Direction - The company continues to focus on investment performance, disciplined capital allocation, and delivering long-term value for global investors and shareholders [11] - Strategic investments have been made in global wealth, insurance solutions, and asset-backed finance, with significant opportunities for continued growth [15] - The company plans to host a shareholder update to share multi-year financial targets and insights into its strategic direction [12] Management's Comments on Operating Environment and Future Outlook - Despite recent market volatility, management remains optimistic about the economic engine, citing strong January data indicating good GDP growth and EBITDA generation [25][26] - The company expects continued growth supported by a diversified fundraising pipeline and improving capital markets conditions [20] - Management acknowledges the complexity of the macro environment but believes it is generally constructive for deployment and realization activity [20] Other Important Information - The company returned a record $1.2 billion of capital to shareholders through dividends and share buybacks during 2025 [19] - The balance sheet remains strong, with $2 billion in cash and over $3 billion in investments [19] Q&A Session Summary Question: Thoughts on sustainability of monetization momentum into 2026 - Management is cautious about extrapolating recent market volatility but notes that January data looks promising for GDP growth and margins [25][26] Question: State of play in direct lending and credit - Management feels well-positioned in direct lending and has added key leaders to enhance origination and integration across private credit strategies [32][34] Question: Expectations for management fee growth in 2026 - Management will provide more details in the upcoming shareholder update but emphasizes the diversification in business mix driving success [52][78] Question: Outlook for CLOs in 2026 - The CLO business has performed well, and management expects another active year, although it may not reach the record levels of the past two years [83] Question: Steps to enhance originations in the credit business - The company has built a strong origination team and achieved record originations in 2025, with plans to continue leveraging its capabilities [88][90]

Carlyle Reports Fourth Quarter and Full-Year 2025 Financial Results FEBRUARY 6, 2026 Carlyle Reports Fourth Quarter and Full-Year 2025 Financial Results WASHINGTON, DC AND NEW YORK, NY – February 6, 2026 – The Carlyle Group Inc. (NASDAQ: CG) today reported its unaudited results for the fourth quarter and full- year ended December 31, 2025. U.S. GAAP Results For Q4 2025 and FY 2025, U.S GAAP results included income before provision for income taxes of $462 million and $1.2 billion, respectively, and a margin ...

Carlyle posts fourth-quarter results that surpassed Wall Street estimates https://t.co/nbN1kUvlyx ...

Financial Performance - Carlyle reported Q4 2025 net income attributable to common stockholders of $358 million, translating to $0.96 per diluted share, and full-year net income of $809 million, or $2.18 per diluted share[15]. - Total revenues for Q4 2025 reached $1.9 billion, a significant increase from $1.03 billion in Q4 2024, while full-year revenues were $4.78 billion, down from $5.43 billion in FY 2024[15]. - Distributable Earnings ("DE") were $436 million for Q4 2025, or $1.01 per common share, and $1.7 billion, or $4.02 per common share for FY 2025[21]. - Fee Related Earnings ("FRE") of $290 million for Q4 2025, up 1% year-over-year, and $1.2 billion for FY 2025, up 12% from FY 2024[34]. - Total segment revenues for FY 2025 were $3,901.5 million, compared to $3,655.4 million in FY 2024, reflecting a growth of 6.7%[84]. - Distributable earnings for FY 2025 were $1,691.2 million, up from $1,525.5 million in FY 2024[84]. - Net income attributable to The Carlyle Group Inc. for FY'25 is projected to be $1,020.4 million, a recovery from a loss of $608.4 million in FY'24[136]. Revenue Sources - Fund management fees increased to $606.8 million in Q4 2025, up from $597.4 million in Q4 2024, and full-year fees rose to $2.40 billion from $2.19 billion[15]. - Incentive fees for Q4 2025 were $55.4 million, compared to $37.3 million in Q4 2024, with full-year incentive fees increasing to $190.5 million from $133.5 million[15]. - Total investment income for FY'25 is projected at $1,341.7 million, compared to $2,254.4 million in FY'24, showing a decrease of 40.5%[136]. Assets Under Management - Carlyle's assets under management stood at $477 billion as of December 31, 2025, reflecting strong investor confidence and disciplined execution of strategy[7]. - Total Assets Under Management reached $477 billion, an 8% increase year-over-year, with Fee-earning Assets Under Management at $337 billion, up 11% year-over-year[22]. - Performance Fee Eligible AUM increased by 3% to $236 billion, primarily due to inflows in Alplnvest funds and an 8% appreciation across the carry fund portfolio[47]. - Total AUM for Global Private Equity was flat at $164 billion as of December 31, 2025, with inflows of $1.3 billion offset by realizations[67]. - Total AUM reached $211 billion as of December 31, 2025, a 1% increase from the prior quarter, driven by inflows of $5.4 billion and market activity[73]. Expenses and Compensation - Total expenses for Q4 2025 were $1.38 billion, up from $800.7 million in Q4 2024, with significant increases in cash-based and equity-based compensation[15]. - The total compensation and benefits for FY'25 are projected to be $2,206.2 million, a decrease from $2,704.9 million in FY'24, reflecting a reduction of approximately 18.4%[136]. - Equity-based compensation expenses for FY'25 are expected to be $376.6 million, a decrease from $476.5 million in FY'24, reflecting a reduction of approximately 21%[123]. Shareholder Returns - The company declared a quarterly dividend of $0.35 per common share, payable on February 20, 2026[4]. - The dividend per common share for FY 2025 was $1.40, with a consistent quarterly dividend of $0.35[116]. - The total cost of shares repurchased and retired during the period was $686.5 million[117]. Market Outlook and Strategy - Carlyle anticipates entering 2026 with strong momentum and a focus on long-term value creation for investors and portfolio companies[6]. - The company has indicated plans for market expansion and new product development, although specific details were not disclosed in the earnings call[126]. - Future outlook includes continued market expansion and potential acquisitions to drive growth[157]. Performance Metrics - The gross multiple on invested capital (MOIC) for various funds ranged from 1.1x to 2.9x, indicating strong performance across different vintages[112]. - The Net Internal Rate of Return (Net IRR) represents an annualized return on Limited Partner invested capital after the impact of all management fees and expenses, with certain funds potentially generating accrued performance revenues below the preferred return hurdle[171]. - The estimated effective tax rate for distributable earnings was 13.9% for FY 2025, influenced by tax deductions from restricted stock units[116].